Loading...

Cohen, Pinchas

Title(s)Professor, Pediatrics
SchoolPeds - Endocrinology
Phone3108256244
vCardDownload vCard

    Collapse Research 
    Collapse Research Activities and Funding
    Ethnic-Specific Mitochondrial DNA Variations that Contribute to Dementia
    NIH/NIA R56AG062693Aug 15, 2019 - Jul 31, 2020
    Role: Principal Investigator
    Humanin is an AD resilience factor through its interaction with APOE4
    NIH/NIA RF1AG061834Sep 30, 2018 - Jun 30, 2023
    Role: Principal Investigator
    Role of GPR120 and Macrophages in Dietary Omega-3 Fatty Acid Inhibition of Prostate Cancer
    NIH/NCI R01CA231219Sep 17, 2018 - Aug 31, 2023
    Role: Co-Principal Investigator
    Dietary Restriction, GH/IGF-1 & Mechanisms of Cellular Protection and Regeneration
    NIH/NIA P01AG055369Feb 15, 2018 - Jan 31, 2023
    Role: Co-Principal Investigator
    Plasma Mitochondrial Peptide Assays as Biomarkers of Environmental Toxin Exposure
    NIH/NIEHS R01ES020812Sep 19, 2011 - Sep 21, 2012
    Role: Principal Investigator
    Humanin and Type 2 Diabetes
    NIH/NIDDK R21DK089447Sep 1, 2011 - Aug 31, 2013
    Role: Co-Principal Investigator
    Novel Mitochondrially Encoded Peptides and Their Role in Health and Disease
    NIH/NIGMS R01GM090311Sep 30, 2009 - Sep 21, 2012
    Role: Principal Investigator
    A family of novel mitochondrially-encoded peptides and their role in aging
    NIH/NIA R01AG034430Jul 15, 2009 - Jun 30, 2014
    Role: Principal Investigator
    The Role of IGF2 in Fetal Growth Restriction
    NIH/NICHD R01HD047013Jun 1, 2004 - Mar 31, 2010
    Role: Principal Investigator
    IGF-I: A Nutrition-Regulated Target in Prostate Cancer
    NIH/NCI R01CA100938Jun 13, 2003 - May 31, 2008
    Role: Principal Investigator
    Genomic and Non-Genomic Effects of IGFBP-3 on Apoptosis
    NIH/NIA R01AG020954Sep 30, 2001 - Aug 31, 2006
    Role: Principal Investigator
    IGF AXIS IN ASTHMA
    NIH/NIAID R01AI040203Apr 1, 1998 - Mar 31, 2004
    Role: Principal Investigator
    IGF AXIS ABNORMALITIES IN BPH
    NIH/NIDDK R01DK047591Sep 30, 1993 - Mar 31, 1999
    Role: Principal Investigator

    Collapse ORNG Applications 
    Collapse Clinical Trials

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
    List All   |   Timeline
    1. Cohen P, Rogol AD, Weng W, Kappelgaard AM, Rosenfeld RG, Germak J. Efficacy of IGF-based growth hormone (GH) dosing in nonGH-deficient (nonGHD) short stature children with low IGF-I is not related to basal IGF-I levels. Clin Endocrinol (Oxf). 2013 Mar; 78(3):405-14. PMID: 22924571.
      View in: PubMed
    2. Cohen P, Germak J, Rogol AD, Weng W, Kappelgaard AM, Rosenfeld RG. Variable degree of growth hormone (GH) and insulin-like growth factor (IGF) sensitivity in children with idiopathic short stature compared with GH-deficient patients: evidence from an IGF-based dosing study of short children. J Clin Endocrinol Metab. 2010 May; 95(5):2089-98. PMID: 20207829.
      View in: PubMed
    3. Keni J, Cohen P. Optimizing growth hormone dosing in children with idiopathic short stature. Horm Res. 2009 Jan; 71 Suppl 1:70-4. PMID: 19153511.
      View in: PubMed
    4. Cohen P, Rogol AD, Deal CL, Saenger P, Reiter EO, Ross JL, Chernausek SD, Savage MO, Wit JM. Consensus statement on the diagnosis and treatment of children with idiopathic short stature: a summary of the Growth Hormone Research Society, the Lawson Wilkins Pediatric Endocrine Society, and the European Society for Paediatric Endocrinology Workshop. J Clin Endocrinol Metab. 2008 Nov; 93(11):4210-7. PMID: 18782877.
      View in: PubMed
    5. Cohen P, Rogol AD, Howard CP, Bright GM, Kappelgaard AM, Rosenfeld RG. Insulin growth factor-based dosing of growth hormone therapy in children: a randomized, controlled study. J Clin Endocrinol Metab. 2007 Jul; 92(7):2480-6. PMID: 17356043.
      View in: PubMed
    6. Cohen P. Controversy in clinical endocrinology: problems with reclassification of insulin-like growth factor I production and action disorders. J Clin Endocrinol Metab. 2006 Nov; 91(11):4235-6. PMID: 16954153.
      View in: PubMed
    7. Cohen P. Insulin-like growth factor binding protein-3: insulin-like growth factor independence comes of age. Endocrinology. 2006 May; 147(5):2109-11. PMID: 16617154.
      View in: PubMed
    8. Cohen P. Overview of the IGF-I system. Horm Res. 2006; 65 Suppl 1:3-8. PMID: 16508327.
      View in: PubMed
    9. Ali O, Cohen P. Insulin-like growth factors and their binding proteins in children born small for gestational age: implication for growth hormone therapy. Horm Res. 2003; 60 Suppl 3:115-23. PMID: 14671408.
      View in: PubMed
    10. Cohen P, Bright GM, Rogol AD, Kappelgaard AM, Rosenfeld RG. Effects of dose and gender on the growth and growth factor response to GH in GH-deficient children: implications for efficacy and safety. J Clin Endocrinol Metab. 2002 Jan; 87(1):90-8. PMID: 11788629.
      View in: PubMed
    11. Cohen P. Clinical implications of the IGF-cancer connection. Growth Horm IGF Res. 2001 Dec; 11(6):336-8. PMID: 11914020.
      View in: PubMed
    12. Cohen P, Clemmons DR, Rosenfeld RG. Does the GH-IGF axis play a role in cancer pathogenesis? Growth Horm IGF Res. 2000 Dec; 10(6):297-305. PMID: 11161960.
      View in: PubMed
    13. Cohen P, Nunn SE, Peehl DM. Transforming growth factor-beta induces growth inhibition and IGF-binding protein-3 production in prostatic stromal cells: abnormalities in cells cultured from benign prostatic hyperplasia tissues. J Endocrinol. 2000 Feb; 164(2):215-23. PMID: 10657857.
      View in: PubMed